ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Pintec Technology Holdings Ltd
NASDAQ:PT
|
CN |
|
FNB Corp
NYSE:FNB
|
US |
|
Amtech Systems Inc
NASDAQ:ASYS
|
US |
|
D
|
Digital Network SA
WSE:DIG
|
PL |
|
A
|
Adsouth Partners Inc
OTC:ASPR
|
US |
Wall Street
Price Targets
ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ACAD
is 32.37 USD
with a low forecast of 17.17 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACAD's stock price target?
Price Target
32.37
USD
According to Wall Street analysts, the average 1-year price target for
ACAD
is 32.37 USD
with a low forecast of 17.17 USD and a high forecast of 47.25 USD.
What is ACADIA Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
14%
The
compound annual growth rate
of ACADIA Pharmaceuticals Inc's revenue for the next 3 years is
14%.
What is ACADIA Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
41%
The
compound annual growth rate
of ACADIA Pharmaceuticals Inc's operating income for the next 3 years is
41%.
What is ACADIA Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-8%
The
compound annual growth rate
of ACADIA Pharmaceuticals Inc's net income for the next 3 years is
-8%.
